Partial Irradiation Equal to Whole-Breast Irradiation in Preventing Cancer Recurrence: Presented at ASTRO
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Partial Irradiation Equal to Whole-Breast Irradiation in Preventing Cancer Recurrence: Presented at ASTRO

By Martha Kerr, BSN

BOSTON -- September 24, 2008 -- Accelerated partial breast irradiation (APBI) using balloon brachytherapy for 1 week is as effective for prevention of recurrence in early-stage breast cancer as a standard 6- to 7-week course of whole-breast irradiation, investigators reported here at the American Society for Therapeutic Radiology and Oncology (ASTRO) 50th Annual Meeting.

In the American Society of Breast Surgeons' MammoSite Radiation Therapy System (RTS) Registry Trial, Peter D. Beitsch, MD, Medical City Dallas Hospital, Dallas, Texas, and colleagues evaluated data from 1,449 primary early-stage breast tumours who were treated with balloon brachytherapy using the MammoSite RTS.

In a presentation on September 22, Dr. Beitsch reported findings on 400 women who were followed for nearly 4 years. His team found that women treated with APBI using balloon brachytherapy "had essentially the same cancer recurrence rates" as those that received standard radiation treatment.

Four-year actuarial survival was 93.9%, disease-free survival was 88.9%, and cancer-speci€c survival was 100.0%, Dr. Beitsch reported.

The results with 1 week of balloon brachytherapy may "actually increase the rate of breast conservation," he said, because standard radiation treatment, consisting of 6 or more weeks of treatment, after lumpectomy may not be possible for some women.

[Presentation title: Recurrence and Survival in the American Society of Breast Surgeons (ASBS) MammoSite RTS Registry Trial. Abstract 5]

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities